Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survivalHelene Doubre, Isabelle Monnet, Reza Azarian, et al.
Scientific Reports|February 18, 2016
Ion-shaping of embedded gold hollow nanoshells into vertically aligned prolate morphologiesPierre-Eugéne Coulon, Julia Amici, Marie-Claude Clochard, et al.
Cancer Medicine|October 13, 2018
Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPCPaul Lesueur, Alexandre Escande, Juliette Thariat, et al.
Chest|June 18, 2002
Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II studyIsabelle Monnet, Jean-Luc Breau, Denis Moro, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2014
Prospective screening for ALK: clinical features and outcome according to ALK statusVincent Fallet, Jacques Cadranel, Hélène Doubre, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational studyIsabelle Monnet, Clarisse Audigier-Valette, Nicolas Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06)Chrystèle Locher, Nicolas Pourel, Hervé Le Caer, et al.
Lung Cancer (Amsterdam, Netherlands)|March 23, 2020
Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohortMateo Sanchis-Borja, Charles Ricordel, Anne Marie Chiappa, et al.
Oncology|October 3, 2018
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in FranceLaurence Bigay-Gamé, Suzanna Bota, Laurent Greillier, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2021
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, et al.
Pageof 12